Image Ben Hargreaves Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market. R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions. Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards. Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike Load more results
Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market.
R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions.
Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.
Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News Norgine gets first EU approval for WHIM syndrome therapy Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
